About Us
Step into the world of Taste of Cannabis, where we’re spearheading the cannabis industry's wellness revolution in South Africa. As a trailblazer in the CBD products market, we're not just riding the green wave – we’re creating it.
As pioneers in the cannabis market, we are committed to enhancing health, wellness, and recreational enjoyment.
Founded in 2019, TOC offers a diverse range of CBD and THC products, known for their quality and consistency. Our CBD line provides natural solutions for pain relief, improved sleep and anxiety reduction, while our THC products cater to both health and recreational needs.Â
Our Philosophy
We believe in the power of cannabis to enhance wellbeing and foster inclusivity. At the heart of our success is our customer-centric philosophy. We actively engage with our customers, continuously developing new and exciting products to meet evolving preferences.Â
Our Commitment
We uphold the highest standards to ensure quality and consistency. We select our suppliers based on strict criteria, blending international and local excellence. Each batch is produced using Good Manufacturing Practices (GMP) and undergoes rigorous testing.
Social Responsibility
We are committed to social equity and responsibility. As a platinum member donator to Fields of Green for All, we actively support their mission to reform South Africa’s cannabis laws. Their Full Spectrum Manifesto for legal regulation aligns with our values of inclusivity, sustainability and human rights, ensuring every citizen can participate in the legal cannabis economy. Together, we are working towards a fair and equitable cannabis industry for all South Africans.
Advocacy and Legal Milestones
We take pride in our active involvement in shaping cannabis law and work closely with government and industry bodies, participating in key meetings and lobby actions, as well as forming alliances to advocate for a fair and inclusive cannabis industry. Our efforts have been integral to significant milestones, including the decriminalisation of cannabis and its declassification as a schedule 1 drug, culminating in the Private Consumptions Act on 29 May 2024.Â